These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6198816)

  • 21. Simulated digestion for testing the stability of edible vaccine based on Cucumber mosaic virus (CMV) chimeric particle display Hepatitis C virus (HCV) peptide.
    Vitti A; Nuzzaci M; Condelli V; Piazzolla P
    Methods Mol Biol; 2014; 1108():41-56. PubMed ID: 24243239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell epitopes in coxsackievirus B4 structural proteins concentrate in regions conserved between enteroviruses.
    Marttila J; Hyöty H; Vilja P; Härkönen T; Alho A; Roivainen M; Hyypiä T; Ilonen J
    Virology; 2002 Feb; 293(2):217-24. PubMed ID: 11886241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection from a peptide library of the antigenic determinants of a protein.
    Castagnoli L; Vetriani C; Gonfloni S; Felici F; Vispo NS; Cesareni G
    Year Immunol; 1993; 7():41-9. PubMed ID: 7690508
    [No Abstract]   [Full Text] [Related]  

  • 24. [Approaches to the design of antiviral vaccines (a theoretical review)].
    Dzagurov SG; Gnuni GM; Khvoles AG
    Vopr Virusol; 1984; 29(2):137-40. PubMed ID: 6203226
    [No Abstract]   [Full Text] [Related]  

  • 25. Nature of the 3'-terminal sequences of the plus and minus strands of the S1 gene of reovirus serotypes 1, 2 and 3.
    Li JK; Keene JD; Scheible PP; Joklik WK
    Virology; 1980 Aug; 105(1):41-51. PubMed ID: 6158163
    [No Abstract]   [Full Text] [Related]  

  • 26. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Structural protective antigens of viruses used for the development of a new type of chemical vaccines].
    Kostiukov VI; Iarov AI; Zezerov EG
    Vopr Virusol; 1982; (1):5-11. PubMed ID: 7041426
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity.
    Cardoso AI; Blixenkrone-Moller M; Fayolle J; Liu M; Buckland R; Wild TF
    Virology; 1996 Nov; 225(2):293-9. PubMed ID: 8918915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the evolutionary pattern of feline panleukopenia virus and canine parvovirus.
    Horiuchi M; Yamaguchi Y; Gojobori T; Mochizuki M; Nagasawa H; Toyoda Y; Ishiguro N; Shinagawa M
    Virology; 1998 Sep; 249(2):440-52. PubMed ID: 9791034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity.
    Hoshino Y; Jones RW; Chanock RM; Kapikian AZ
    J Med Virol; 1997 Apr; 51(4):319-25. PubMed ID: 9093947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants.
    Spriggs DR; Fields BN
    Nature; 1982 May; 297(5861):68-70. PubMed ID: 6175910
    [No Abstract]   [Full Text] [Related]  

  • 33. [Molecular biology and virus research].
    Winnacker EL
    Internist (Berl); 1985 Feb; 26(2):58-62. PubMed ID: 3884529
    [No Abstract]   [Full Text] [Related]  

  • 34. Tapping the immunological repertoire to produce antibodies of predetermined specificity.
    Lerner RA
    Nature; 1982 Oct; 299(5884):593-6. PubMed ID: 6181415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the gene coding for the hemagglutinin of reovirus.
    Weiner HL; Ramig RF; Mustoe TA; Fields BN
    Virology; 1978 May; 86(2):581-4. PubMed ID: 566483
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular approaches to vaccines.
    Bachrach HL
    Basic Life Sci; 1986; 37():217-42. PubMed ID: 3085649
    [No Abstract]   [Full Text] [Related]  

  • 37. Prospects for oral vaccination using recombinant bacteria expressing viral epitopes.
    Schödel F
    Adv Virus Res; 1992; 41():409-46. PubMed ID: 1374212
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant DNA. Dos and don'ts of genetic release.
    Glover S
    Nature; 1988 May; 333(6171):297-8. PubMed ID: 3163777
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoclonal antibodies: a potentially powerful tool in the diagnosis and treatment of infectious diseases.
    Spira G; Pollock RR; Bargellesi A; Scharff MD
    Eur J Clin Microbiol; 1985 Jun; 4(3):251-6. PubMed ID: 2410264
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterologous transactivation among viruses.
    Tevethia MJ; Spector DJ
    Prog Med Virol; 1989; 36():120-90. PubMed ID: 2685910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.